Any FDA guidance eliminating or streamlining the interchangeability designation would disproportionately benefit commercial-stage biosimilar developers in the subcutaneous self-injection market (adalimumab, ixekizumab, secukinumab biosimilars) where pharmacy-level substitution is the primary market share mechanism
High dose ( 0.5 mg/kg/d) or long-term use may lead to hypoglycemia, especially in patients with diabetes or insulin resistance
What lifestyle habits will you establish during treatment that will sustain your weight loss if and when you stop the medication
L-Glutamine, if used, is like ensuring the windows are properly sealedhelpful, but not the structure itself
Despite the numerous benefits, clinicians must be careful while prescribing semaglutide because each brand has different preparations and variable dosage schemes linked to different benefits and side effects
While this is a necessary first step, it frequently creates highly reactive, electrophilic intermediate metabolites that are actually more toxic and dangerous than the original parent compound